Germline and somatic mutations across (i.e., MMR versus HR) and within (i.e., BRCA1 versus BRCA2) DDR pathways showed variable associations with TMB, neoantigen loads, and indel neoantigen hotspots in a cancer-dependent manner. This evidence concerns the gene BRCA2 and cancer.